https://kentathlonepharmagroup.com/
Our strategic focus is on developing, in-licensing, acquiring and commercialising value-added medicines. June 3, 2026 Kent Pharma Achieves EcoVadis Gold Rating for the Third Consecutive Year The Kent-Athlone Pharma…